Cormorant Asset Management LP 13D/13G Filings for NOVUS THERAPEUTICS INC (NVUS)

Cormorant Asset Management LP 13D and 13G filings for NOVUS THERAPEUTICS INC:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-01-04
4:01 pm
Purchase
2020-12-22 13G NOVUS THERAPEUTICS INC
NVUS
Cormorant Asset Management LP 1,415,500
9.890%
1,415,500increase
(New Position)
Filing